BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Breuhahn K, Schirmacher P. Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma. World J Gastroenterol 2008; 14(11): 1690-1698 [PMID: 18350600 DOI: 10.3748/wjg.14.1690]
URL: https://www.wjgnet.com/1007-9327/full/v14/i11/1690.htm
Number Citing Articles
1
Haijian Zhang, Min Yao, Wei Wu, Liwei Qiu, Wenli Sai, Junling Yang, Wenjie Zheng, Jianfei Huang, Dengfu Yao. Up-regulation of annexin A2 expression predicates advanced clinicopathological features and poor prognosis in hepatocellular carcinomaTumor Biology 2015; 36(12): 9373 doi: 10.1007/s13277-015-3678-6
2
Na Huang, Fanpu Ji, Shu Zhang, Yansong Pu, An Jiang, Rui Zhou, Yuanyuan Ji, Wei Wei, Jun Yang, Zongfang Li. Effect of Splenectomy on Serum Cytokine Profiles in Hepatitis B Virus-Related Cirrhosis Patients with Portal HypertensionViral Immunology 2018; 31(5): 371 doi: 10.1089/vim.2017.0176
3
Zara Zelenko, Derek LeRoith, Emily J. Gallagher. Murine Models, Energy Balance, and CancerEnergy Balance and Cancer 2015; 10: 153 doi: 10.1007/978-3-319-16733-6_8
4
G. Escobedo, M.C. Romano, J. Morales-Montor. Differentialin vitroeffects of insulin onTaenia crassicepsandTaenia soliumcysticerciJournal of Helminthology 2009; 83(4): 403 doi: 10.1017/S0022149X09990265
5
Arezoo Gowhari Shabgah, Fatemeh Ezzatifar, Surendar Aravindhan, Angelina Olegovna Zekiy, Majid Ahmadi, Seyed Mohammad Gheibihayat, Jamshid Gholizadeh Navashenaq. Shedding more light on the role of Midkine in hepatocellular carcinoma: New perspectives on diagnosis and therapyIUBMB Life 2021; 73(4): 659 doi: 10.1002/iub.2458
6
Min Yao, Li Wang, Junling Yang, Xiaodi Yan, Yin Cai, Dengfu Yao. IGF-I receptor as an emerging potential molecular-targeted for hepatocellular carcinoma in vitro and in vivoTumor Biology 2016; 37(11): 14677 doi: 10.1007/s13277-016-5296-3
7
Diego Francesco Calvisi, Matthias Evert, Frank Dombrowski. Hepatocarcinogenesis following pancreatic islet transplantation in streptozotocin- and autoimmune-diabetic ratsArchives of Physiology and Biochemistry 2009; 115(2): 97 doi: 10.1080/13813450902870457
8
Tong Liu, Zheng Wang, Leiguang Ye, Yuran Duan, Hongfei Jiang, Haiyan He, Liwei Xiao, Qingang Wu, Yan Xia, Mengke Yang, Ke Wu, Meisi Yan, Guimei Ji, Yuli Shen, Lei Wang, Lin Li, Peixiang Zheng, Bofei Dong, Fei Shao, Xu Qian, Rilei Yu, Zhiren Zhang, Zhimin Lu, Daqian Xu. Nucleus-exported CLOCK acetylates PRPS to promote de novo nucleotide synthesis and liver tumour growthNature Cell Biology 2023;  doi: 10.1038/s41556-022-01061-0
9
Katsuhiro Ogawa. Molecular pathology of early stage chemically induced hepatocarcinogenesisPathology International 2009; 59(9): 605 doi: 10.1111/j.1440-1827.2009.02416.x
10
Xiancheng Chen, Xiaojuan Lin, Meng Li. Comprehensive Modulation of Tumor Progression and Regression with Periodic Fasting and Refeeding Circles via Boosting IGFBP-3 Loops and NK ResponsesEndocrinology 2012; 153(10): 4622 doi: 10.1210/en.2011-2101
11
Jing Qian, Dengfu Yao, Zhizhen Dong, Wei Wu, Liwei Qiu, Ninghua Yao, Shanshan Li, Yinzhu Bian, Zhiwei Wang, Gongsheng Shi. Characteristics of Hepatic IGF-II Expression and Monitored Levels of Circulating IGF-II mRNA in Metastasis of Hepatocellular CarcinomaAmerican Journal of Clinical Pathology 2010; 134(5): 799 doi: 10.1309/AJCPTFDSE2V3LCZP
12
Eliot Osher, Valentine M. Macaulay. Therapeutic Targeting of the IGF AxisCells 2019; 8(8): 895 doi: 10.3390/cells8080895
13
Zhizhen Dong, Min Yao, Li Wang, Xiaodi Yan, Xing Gu, Yun Shi, Ninghua Yao, Liwei Qiu, Wei Wu, Dengfu Yao. Abnormal expression of insulin-like growth factor-I receptor in hepatoma tissue and its inhibition to promote apoptosis of tumor cellsTumor Biology 2013; 34(6): 3397 doi: 10.1007/s13277-013-0912-y
14
Junlai Liu, Xiao Hu, Jie Chen, Xinqi Li, Lu Wang, Binbin Wang, Wenbo Peng, Cuiwei Yang, Zhijie Li, Yan Chen, Yue J. Wang, Chuanjiang Li, Xiajun Li, Fang Yan, Yunfang Wang, Changzhen Shang, Xin Wang, Tao Chen, Pengyu Huang. Pericentral hepatocytes produce insulin‐like growth factor‐2 to promote liver regeneration during selected injuries in miceHepatology 2017; 66(6): 2002 doi: 10.1002/hep.29340
15
K. Breuhahn. Molekulare Progressionsmechanismen der humanen HepatokarzinogeneseDer Pathologe 2010; 31(S2): 170 doi: 10.1007/s00292-010-1337-7
16
Shaohui Tang, Yanfang Chen, Shufen Feng, Tingzhuang Yi, Xuyou Liu, Qiang Li, Zhilong Liu, Cuiping Zhu, Jianjun Hu, Xi Yu, Min Wang, Guoli Cao, Hui Tang, Caiqun Bie, Feng Ma, Huijun Tang, Gang Du, Jianwei Huang. MiR-483-5p promotes IGF-II transcription and is associated with poor prognosis of hepatocellular carcinomaOncotarget 2017; 8(59): 99871 doi: 10.18632/oncotarget.21737
17
Mohammed A. F. Elewa, Mohammed M. Al-Gayyar, Mona F. Schaalan, Khaled H. Abd El Galil, Mohamed A. Ebrahim, Mamdouh M. El-Shishtawy. Hepatoprotective and anti-tumor effects of targeting MMP-9 in hepatocellular carcinoma and its relation to vascular invasion markersClinical & Experimental Metastasis 2015; 32(5): 479 doi: 10.1007/s10585-015-9721-6
18
Zijia Wang, Haofeng Xiong, Yijie Zuo, Shujun Hu, Chao Zhu, Anjie Min. PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathwayCell Cycle 2022; 21(5): 477 doi: 10.1080/15384101.2021.2021722
19
Yan Ma, Yanfang Chen, Lei Chen, Zhi Liu, Mio-Leng Ieong, Fei Gao, Wei Huang. Promotion of Insulin-like growth factor II in cell proliferation and epithelial–mesenchymal transition in hepatocellular carcinomaJournal of Cancer Research and Therapeutics 2018; 14(4): 844 doi: 10.4103/jcrt.JCRT_605_17
20
Ulrick Espelund, Henning Grønbæk, Gerda Elisabeth Villadsen, Kira Simonsen, Poul Frølund Vestergaard, Jens Otto Lunde Jørgensen, Allan Flyvbjerg, Hendrik Vilstrup, Jan Frystyk. The Circulating IGF System in Hepatocellular Carcinoma: The Impact of Liver Status and TreatmentGrowth Hormone & IGF Research 2015; 25(4): 174 doi: 10.1016/j.ghir.2015.05.002
21
Yilin Wang, Xiaolong Zhang, Chao Zou, Hsiang-Fu Kung, Marie C. Lin, Andreas Dress, Fiona Wardle, Bing-Hua Jiang, Lihui Lai. miR-195 inhibits tumor growth and angiogenesis through modulating IRS1 in breast cancerBiomedicine & Pharmacotherapy 2016; 80: 95 doi: 10.1016/j.biopha.2016.03.007
22
Tamara Severi, Hannah van Malenstein, Chris Verslype, Jos F van Pelt. Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targetsActa Pharmacologica Sinica 2010; 31(11): 1409 doi: 10.1038/aps.2010.142
23
Bo-Jun Tai, Min Yao, Wen-Jie Zheng, Yu-Cheng Shen, Li Wang, Jian-Ying Sun, Meng-Na Wu, Zhi-Zhen Dong, Deng-Fu Yao. Alteration of oncogenic IGF-II gene methylation status associates with hepatocyte malignant transformationHepatobiliary & Pancreatic Diseases International 2019; 18(2): 158 doi: 10.1016/j.hbpd.2019.01.003
24
Kimberly Terry, Mehmet Sitki Copur. Molecular Targeted Therapy of Hepatocellular CarcinomaJournal of Cancer Therapy 2013; 4(02): 426 doi: 10.4236/jct.2013.42A052
25
Yusuf Yilmaz, Yasar Colak, Ramazan Kurt, Ebubekir Senates, Fatih Eren. Linking Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: From Bedside to Bench and BackTumori Journal 2013; 99(1): 10 doi: 10.1177/030089161309900102
26
Karen Bonefeld, Søren Møller. Insulin-like growth factor-I and the liverLiver International 2011; 31(7): 911 doi: 10.1111/j.1478-3231.2010.02428.x
27
LU YUE, YING WANG, HUAMAO WANG, HUIPING GAO, JUN LIANG, AIHUA SUI, JINYU XIANG, FANG ZHOU, CONGCONG XU, WENWEN ZHAO, WANHUA LIANG, RUYONG YAO. Inhibition of hepatocellular carcinoma cell growth by an anti-insulin-like growth factor-I receptor monoclonal antibodyOncology Reports 2012; 28(4): 1453 doi: 10.3892/or.2012.1960
28
YU GU, YUQIAO XU, LINA JIANG, XIANGMEI CAO, FANG LIU, HANG LI, LIYING ZHANG, ZENGSHAN LI, JING LI, JING YE, QING LI. Differentially expressed microRNAs in Huh-7 cells expressing HCV core genotypes 3a or 1b: Potential functions and downstream pathwaysInternational Journal of Molecular Medicine 2012; 30(2): 374 doi: 10.3892/ijmm.2012.991
29
Astrid Slany, Anastasia Meshcheryakova, Agnes Beer, Hendrik Jan Ankersmit, Verena Paulitschke, Christopher Gerner. Plasticity of fibroblasts demonstrated by tissue-specific and function-related proteome profilingClinical Proteomics 2014; 11(1) doi: 10.1186/1559-0275-11-41
30
Sameer A. Greenall, John D. Bentley, Lesley A. Pearce, Judith A. Scoble, Lindsay G. Sparrow, Nicola A. Bartone, Xiaowen Xiao, Robert C. Baxter, Leah J. Cosgrove, Timothy E. Adams. Biochemical Characterization of Individual Human Glycosylated pro-Insulin-like Growth Factor (IGF)-II and big-IGF-II Isoforms Associated with CancerJournal of Biological Chemistry 2013; 288(1): 59 doi: 10.1074/jbc.M112.432013
31
Craig I. Campbell, James J. Petrik, Roger A. Moorehead. Insulin-like Growth Factors and Cancer2012; : 179 doi: 10.1007/978-1-4614-0598-6_9
32
O. V. Smirnova, F. A. Gershkoron. Role of insulin-like growth factor, pro-inflammatory and anti-inflammatory cytokines, transcription factors and adipokines in development of hepatocellular carcinoma in metabolic syndromeMedical Immunology (Russia) 2022; 24(6): 1109 doi: 10.15789/1563-0625-ROI-2533
33
Tran Duc DUNG, Chih-Chung FENG, Wei-Wen KUO, Peiying PAI, Li-Chin CHUNG, Sheng-Huang CHANG, Hsi-Hsien HSU, Fuu-Jen TSAI, Yueh-Min LIN, Chih-Yang HUANG. Suppression of Plasminogen Activators and the MMP-2/-9 Pathway by aZanthoxylum avicennaeExtract to Inhibit the HA22T Human Hepatocellular Carcinoma Cell Migration and Invasion Effectsin Vitroandin VivoviaPhosphatase 2A ActivationBioscience, Biotechnology, and Biochemistry 2013; 77(9): 1814 doi: 10.1271/bbb.130060
34
Yutaka Midorikawa, Yasuyuki Sugiyama, Hiroyuki Aburatani. Molecular targets for liver cancer therapy: From screening of target genes to clinical trialsHepatology Research 2010; 40(1): 49 doi: 10.1111/j.1872-034X.2009.00583.x
35
Yulyana Yulyana, Ivy A W Ho, Kian Chuan Sia, Jennifer P Newman, Xin Yi Toh, Berwini B Endaya, Jerry K Y Chan, Massimiliano Gnecchi, Hung Huynh, Alexander Y F Chung, Kiat Hon Lim, Hui Sun Leong, Narayanan Gopalakrishna Iyer, Kam Man Hui, Paula Y P Lam. Paracrine Factors of Human Fetal MSCs Inhibit Liver Cancer Growth Through Reduced Activation of IGF-1R/PI3K/Akt SignalingMolecular Therapy 2015; 23(4): 746 doi: 10.1038/mt.2015.13
36
Jin Gao, Jon W. Chesebrough, Susan A. Cartlidge, Sally-Ann Ricketts, Leonard Incognito, Margaret Veldman-Jones, David C. Blakey, Mohammad Tabrizi, Bahija Jallal, Pamela A. Trail, Steven Coats, Klaus Bosslet, Yong S. Chang. Dual IGF-I/II–Neutralizing Antibody MEDI-573 Potently Inhibits IGF Signaling and Tumor GrowthCancer Research 2011; 71(3): 1029 doi: 10.1158/0008-5472.CAN-10-2274
37
Daniel T. Dransfield, Edward H. Cohen, Qing Chang, Lindsay G. Sparrow, John D. Bentley, Olan Dolezal, Xiaowen Xiao, Thomas S. Peat, Janet Newman, Patricia A. Pilling, Tram Phan, Ilka Priebe, Gemma V. Brierley, Niksa Kastrapeli, Kris Kopacz, Diana Martik, Dina Wassaf, Douglas Rank, Greg Conley, Yan Huang, Timothy E. Adams, Leah Cosgrove. A Human Monoclonal Antibody against Insulin-Like Growth Factor-II Blocks the Growth of Human Hepatocellular Carcinoma Cell Lines In vitro and In vivo Molecular Cancer Therapeutics 2010; 9(6): 1809 doi: 10.1158/1535-7163.MCT-09-1134
38
Philippe Couvert, Alain Carrié, Sophie Tezenas du Montcel, Jenny Vaysse, Angela Sutton, Nathalie Barget, Jean-Claude Trinchet, Michel Beaugrand, Nathalie Ganne, Philippe Giral, Jamel Chelly. Insulin-like growth factor 2 gene methylation in peripheral blood mononuclear cells of patients with hepatitis C related cirrhosis or hepatocellular carcinomaClinics and Research in Hepatology and Gastroenterology 2012; 36(4): 345 doi: 10.1016/j.clinre.2012.06.013
39
Jiangwei Li, Ren Li, Wei Jiang, Jin Sun, Jun Li, Ying Guo, Kai Zhu, Chen Zhang, Guangyao Kong, Zongfang Li. Splenic serum from portal hypertensive patients enhances liver stem cell proliferation and self-renewal via the IGF-II/ERK signaling pathwayDigestive and Liver Disease 2020; 52(2): 205 doi: 10.1016/j.dld.2019.07.014
40
Ying-Chun Shen, Chiun Hsu, Ann-Lii Cheng. Molecular targeted therapy for advanced hepatocellular carcinoma: current status and future perspectivesJournal of Gastroenterology 2010; 45(8): 794 doi: 10.1007/s00535-010-0270-0
41
Anuradha Budhu, Junfang Ji, Xin Wei Wang. Hepatocellular Carcinoma2009; : 131 doi: 10.1007/978-1-60327-376-3_5
42
Hamza Chettouh, Marie Lequoy, Laetitia Fartoux, Corinne Vigouroux, Christèle Desbois‐Mouthon. Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinomaLiver International 2015; 35(10): 2203 doi: 10.1111/liv.12903
43
Melchiorre Cervello, James A. McCubrey, Antonella Cusimano, Nadia Lampiasi, Antonina Azzolina, Giuseppe Montalto. Targeted therapy for hepatocellular carcinoma: novel agents on the horizonOncotarget 2012; 3(3): 236 doi: 10.18632/oncotarget.466
44
Dawn Qingqing Chong, Iain Beehuat Tan, Su-Pin Choo, Han Chong Toh. The evolving landscape of therapeutic drug development for hepatocellular carcinomaContemporary Clinical Trials 2013; 36(2): 605 doi: 10.1016/j.cct.2013.03.013
45
Astrid Slany, Verena J. Haudek, Hannes Zwickl, Nina C. Gundacker, Michael Grusch, Thomas S. Weiss, Katja Seir, Chantal Rodgarkia-Dara, Claus Hellerbrand, Christopher Gerner. Cell Characterization by Proteome Profiling Applied to Primary Hepatocytes and Hepatocyte Cell Lines Hep-G2 and Hep-3BJournal of Proteome Research 2010; 9(1): 6 doi: 10.1021/pr900057t
46
Mark A. Feitelson, Alla Arzumanyan, Helena M. G. P. V. Reis, Marcia M. Clayton, Bill S. Sun, Zhaorui Lian. Molecular Pathology of Liver DiseasesMolecular Pathology Library 2011; 5: 553 doi: 10.1007/978-1-4419-7107-4_37
47
Hamza Chettouh, Laetitia Fartoux, Lynda Aoudjehane, Dominique Wendum, Audrey Clapéron, Yves Chrétien, Colette Rey, Olivier Scatton, Olivier Soubrane, Filomena Conti, Françoise Praz, Chantal Housset, Olivier Rosmorduc, Christèle Desbois-Mouthon. Mitogenic Insulin Receptor-A Is Overexpressed in Human Hepatocellular Carcinoma due to EGFR-Mediated Dysregulation of RNA Splicing FactorsCancer Research 2013; 73(13): 3974 doi: 10.1158/0008-5472.CAN-12-3824
48
Shaohui Tang, Wei Hu, Jianjun Hu, Shenglan Wu, Junfeng Li, Yuhong Luo, Mingrong Cao, Hongke Zhou, Xiangwu Jiang. Hepatitis B virus X protein promotes P3 transcript expression of the insulin‐like growth factor 2 gene via inducing hypomethylation of P3 promoter in hepatocellular carcinomaLiver International 2015; 35(2): 608 doi: 10.1111/liv.12469
49
Cai Qun Bie, Xu You Liu, Ming Rong Cao, Qiu Yan Huang, Hui Jun Tang, Min Wang, Guo Li Cao, Ting Zhuang Yi, Sheng Lan Wu, Wei Jie Xu, Shao Hui Tang. Lentivirus-mediated RNAi knockdown of insulin-like growth factor-1 receptor inhibits the growth and invasion of hepatocellular carcinoma via down-regulating midkine expressionOncotarget 2016; 7(48): 79305 doi: 10.18632/oncotarget.13027
50
Yuan-Yuan Zhang, Harry Hua-Xiang Xia. Novel therapeutic approaches for hepatocellulcar carcinoma: Fact and fictionWorld Journal of Gastroenterology 2008; 14(11): 1641-1642 doi: 10.3748/wjg.14.1641
51
Julia C. Engelmann, Thomas Amann, Birgitta Ott-Rötzer, Margit Nützel, Yvonne Reinders, Jörg Reinders, Wolfgang E. Thasler, Theresa Kristl, Andreas Teufel, Christian G. Huber, Peter J. Oefner, Rainer Spang, Claus Hellerbrand, Sven Nelander. Causal Modeling of Cancer-Stromal Communication Identifies PAPPA as a Novel Stroma-Secreted Factor Activating NFκB Signaling in Hepatocellular CarcinomaPLOS Computational Biology 2015; 11(5): e1004293 doi: 10.1371/journal.pcbi.1004293
52
Natalia Elfimova, Elisabeth Sievers, Hannah Eischeid, Monika Kwiecinski, Andrea Noetel, Heike Hunt, Diana Becker, Peter Frommolt, Maria Quasdorff, Hans Michael Steffen, Peter Nürnberg, Reinhard Büttner, Andreas Teufel, Hans-Peter Dienes, Uta Drebber, Margarete Odenthal. Control of mitogenic and motogenic pathways by miR-198, diminishing hepatoma cell growth and migrationBiochimica et Biophysica Acta (BBA) - Molecular Cell Research 2013; 1833(5): 1190 doi: 10.1016/j.bbamcr.2013.01.023
53
Ahmed Waraky, Eiman Aleem, Olle Larsson. Downregulation of IGF-1 receptor occurs after hepatic linage commitment during hepatocyte differentiation from human embryonic stem cellsBiochemical and Biophysical Research Communications 2016; 478(4): 1575 doi: 10.1016/j.bbrc.2016.08.157
54
Ke Wu, Meisi Yan, Tong Liu, Zheng Wang, Yuran Duan, Yan Xia, Guimei Ji, Yuli Shen, Lei Wang, Lin Li, Peixiang Zheng, Bofei Dong, Qingang Wu, Liwei Xiao, Xueying Yang, Haochen Shen, Ting Wen, Jingjing Zhang, Jinfeng Yi, Yuhan Deng, Xu Qian, Leina Ma, Jing Fang, Qin Zhou, Zhimin Lu, Daqian Xu. Creatine kinase B suppresses ferroptosis by phosphorylating GPX4 through a moonlighting functionNature Cell Biology 2023; 25(5): 714 doi: 10.1038/s41556-023-01133-9
55
Sameer A. Greenall, Jacqueline Donoghue, Terrance G. Johns, Timothy E. Adams. Differential Sensitivity of Human Hepatocellular Carcinoma Xenografts to an IGF-II Neutralizing Antibody May Involve Activated STAT3Translational Oncology 2018; 11(4): 971 doi: 10.1016/j.tranon.2018.05.011
56
Priscilla T.-Y. Law, Arthur K.-K. Ching, Anthony W.-H. Chan, Queenie W.-L. Wong, Chun-Kwok Wong, Ka-Fai To, Nathalie Wong. MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinomaCarcinogenesis 2012; 33(6): 1134 doi: 10.1093/carcin/bgs130